XML 17 R4.htm IDEA: XBRL DOCUMENT v3.25.1
Consolidated Balance Sheets - USD ($)
$ in Millions
Dec. 31, 2024
Dec. 31, 2023
Current Assets    
Cash and cash equivalents $ 1,850 $ 2,392
Restricted cash and cash equivalents 6 411
Accounts and notes receivable - net 2,199 2,370
Inventories 2,130 2,147
Prepaid and other current assets 179 194
Total current assets 6,364 7,514
Property    
Property, plant and equipment 10,956 10,725
Less: Accumulated depreciation 5,188 4,841
Total property, plant and equipment - net 5,768 5,884
Other Assets    
Goodwill 16,567 16,720
Other intangible assets 5,370 5,814
Restricted cash and cash equivalents - noncurrent 36 0
Investments and noncurrent receivables 1,081 1,071
Deferred income tax assets 246 312
Deferred charges and other assets 1,204 1,237
Total other assets 24,504 25,154
Total Assets 36,636 38,552
Current Liabilities    
Short-term borrowings 1,848 0
Accounts payable 1,720 1,675
Income taxes payable 202 154
Accrued and other current liabilities 1,031 1,269
Total current liabilities 4,801 3,098
Long-Term Debt 5,323 7,800
Other Noncurrent Liabilities    
Deferred income tax liabilities 915 1,130
Pension and other post-employment benefits - noncurrent 523 565
Other noncurrent obligations 1,281 1,234
Total other noncurrent liabilities 2,719 2,929
Total Liabilities 12,843 13,827
Commitments and contingent liabilities
Stockholders' Equity    
Common stock (authorized 1,666,666,667 shares of $0.01 par value each; issued 2024: 417,994,343 shares; 2023: 430,110,140 shares) 4 4
Additional paid-in capital 47,922 48,059
Accumulated deficit (23,076) (22,874)
Accumulated other comprehensive loss (1,500) (910)
Total DuPont stockholders' equity 23,350 24,279
Noncontrolling interests 443 446
Total equity 23,793 24,725
Total Liabilities and Equity $ 36,636 $ 38,552